[go: up one dir, main page]

IT9019112A1 - Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina - Google Patents

Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina

Info

Publication number
IT9019112A1
IT9019112A1 IT019112A IT1911290A IT9019112A1 IT 9019112 A1 IT9019112 A1 IT 9019112A1 IT 019112 A IT019112 A IT 019112A IT 1911290 A IT1911290 A IT 1911290A IT 9019112 A1 IT9019112 A1 IT 9019112A1
Authority
IT
Italy
Prior art keywords
calcitonin
pharmaceutical compositions
dosage forms
oral administration
oral
Prior art date
Application number
IT019112A
Other languages
English (en)
Other versions
IT9019112A0 (it
IT1238072B (it
Inventor
Maurizio Cecchettin
Filippo Lattanzi
Riccardo Vanni
Original Assignee
Sclavo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sclavo Spa filed Critical Sclavo Spa
Priority to IT01911290A priority Critical patent/IT1238072B/it
Publication of IT9019112A0 publication Critical patent/IT9019112A0/it
Priority to MX2403990A priority patent/MX24039A/es
Priority to US07/640,811 priority patent/US5441933A/en
Priority to EP19910100509 priority patent/EP0438147A3/en
Priority to KR1019910000675A priority patent/KR910014128A/ko
Priority to CA002034519A priority patent/CA2034519A1/en
Priority to JP3016832A priority patent/JPH04210924A/ja
Publication of IT9019112A1 publication Critical patent/IT9019112A1/it
Application granted granted Critical
Publication of IT1238072B publication Critical patent/IT1238072B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT01911290A 1990-01-19 1990-01-19 Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina IT1238072B (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT01911290A IT1238072B (it) 1990-01-19 1990-01-19 Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
MX2403990A MX24039A (es) 1990-01-19 1990-12-28 Composiciones farmaceuticas que contienen una calcitonina como principio activo.
US07/640,811 US5441933A (en) 1990-01-19 1991-01-14 Pharmaceutical compositions and dosage forms for the oral administration of calcitonin
EP19910100509 EP0438147A3 (en) 1990-01-19 1991-01-17 Pharmaceutical compositions and dosage forms for the oral administration of calcitonin
KR1019910000675A KR910014128A (ko) 1990-01-19 1991-01-17 칼시토닌의 경구투여용 약제학적 조성물 및 용량형
CA002034519A CA2034519A1 (en) 1990-01-19 1991-01-18 Pharmaceutical compositions and dosage forms for the oral administration of calcitonin
JP3016832A JPH04210924A (ja) 1990-01-19 1991-01-18 カルシトニンの経口投与用の製薬組成物及び投薬形態

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT01911290A IT1238072B (it) 1990-01-19 1990-01-19 Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina

Publications (3)

Publication Number Publication Date
IT9019112A0 IT9019112A0 (it) 1990-01-19
IT9019112A1 true IT9019112A1 (it) 1991-07-19
IT1238072B IT1238072B (it) 1993-07-03

Family

ID=11154741

Family Applications (1)

Application Number Title Priority Date Filing Date
IT01911290A IT1238072B (it) 1990-01-19 1990-01-19 Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina

Country Status (7)

Country Link
US (1) US5441933A (it)
EP (1) EP0438147A3 (it)
JP (1) JPH04210924A (it)
KR (1) KR910014128A (it)
CA (1) CA2034519A1 (it)
IT (1) IT1238072B (it)
MX (1) MX24039A (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9120672D0 (en) * 1991-09-28 1991-11-06 Ciba Geigy Ag Pharmaceutical compositions
EP0839526A3 (en) 1996-10-31 1999-01-07 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation with fast buccal disintegration or dissolution
WO1999059544A2 (en) * 1998-05-18 1999-11-25 Takeda Chemical Industries, Ltd. Orally disintegrable tablets
TW585786B (en) 1998-07-28 2004-05-01 Takeda Chemical Industries Ltd Lansoprazole-containing rapidly disintegrable solid pharmaceutical composition
KR100690311B1 (ko) * 1998-12-01 2007-03-09 닥터 레디스 래보러토리즈, 인코포레이티드 새로운 제약 조성물 및 그것의 제조방법
US7067116B1 (en) 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
US7049283B2 (en) 2000-12-06 2006-05-23 Novartis Ag Pharmaceutical compositions for the oral delivery of pharmacologically active agents
ES2199061B1 (es) * 2002-06-10 2005-02-16 Laboratorios Vita, S.A. Comprimidos bucodispersables y procedimiento para su obtencion.
US20040265372A1 (en) * 2003-06-27 2004-12-30 David Wynn Soft tablet containing high molecular weight cellulosics
RS20050835A (sr) * 2004-01-06 2007-08-03 Panacea Biotec Ltd., Sastavi bukalnih doznih oblika za produženo otpuštanje leka i postupak za njihovo dobijanje
WO2006124047A2 (en) * 2004-08-13 2006-11-23 Emisphere Technologies, Inc. Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
US8197858B2 (en) * 2009-02-06 2012-06-12 Mark John Zamoyski Bone microenvironment modulated seizure treatments
US9486947B2 (en) * 2013-09-30 2016-11-08 Gregory D. Graves Phosphorus treatment agent methods of manufacture and use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4151276A (en) * 1975-05-12 1979-04-24 Armour Pharmaceutical Company Method of suppressing gastric acid secretion by the oral administration of calcitonin
US4663309A (en) * 1983-06-29 1987-05-05 University Patents, Inc. Novel peptide hormones with calcitonin-like activity
US4530838A (en) * 1983-07-08 1985-07-23 The Salk Institute For Biological Studies Synthetic calcitonin-gene-related peptides for lowering blood pressure or gastric acid secretion in mammals
JPS61126034A (ja) * 1984-11-26 1986-06-13 Yamanouchi Pharmaceut Co Ltd アルド−スを含有するカルシトニン経鼻剤
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
JPS6210020A (ja) * 1985-07-08 1987-01-19 Kanebo Ltd カルシトニン含有組成物
IT1223132B (it) * 1987-11-13 1990-09-12 Isf Spa Composizione farmaceutica per somministrazione nasale
ES2061688T3 (es) * 1987-11-13 1994-12-16 Smithkline Beecham Farma Composiciones farmaceuticas que comprenden una calcitonina y un glicirricinato como mejorador de la absorcion.

Also Published As

Publication number Publication date
IT9019112A0 (it) 1990-01-19
EP0438147A2 (en) 1991-07-24
EP0438147A3 (en) 1991-10-16
MX24039A (es) 1994-02-28
JPH04210924A (ja) 1992-08-03
US5441933A (en) 1995-08-15
IT1238072B (it) 1993-07-03
CA2034519A1 (en) 1991-07-20
KR910014128A (ko) 1991-08-31

Similar Documents

Publication Publication Date Title
IT9020025A0 (it) Dispositivo per la somministrazione di sostanze medicamentose in polvere
ITBO910024A0 (it) Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale
IE862554L (en) Pharmaceutical compositions
IT8767796A0 (it) Forma farmaceutica di dosaggio per somministrazione orale con erogazione controllata di un ingrediente attivo
MX9101175A (es) Composicion farmaceutica para administracion nasal
ATE219377T1 (de) Neue galenische orale pharmazeutische formulierung
IT1191674B (it) Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale
IT1173705B (it) Formulazione farmaceutica di clometacina per somministrazione orale e procedimento di preparazione
FI950947L (fi) Oraalisesti annettavat farmaseuttiset formulaatiot
DE4291156T1 (de) Verbesserte pharmazeutische Zusammensetzungen
FI955310L (fi) Farmaseuttinen koostumus flavonoidien antamiseksi oraalisesti
ITMI921930A1 (it) Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda
IT9019112A1 (it) Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
ITMI921123A0 (it) Formulazioni farmaceutiche orali contenenti antocianosidi
FI970331L (fi) Lääkkeen antokoostumus virustenvastaisten aineiden nenään toteutettavaa antoa varten
NO950134D0 (no) Formuleringer for oralt administrerte farmasöytiske midler
FI910088A7 (fi) Oraalinen farmaseuttinen koostumus
MX9200146A (es) Composiciones farmaceuticas deglutibles
IT1291340B1 (it) Formulazioni farmaceutiche contenenti colostro e uso del colostro per il trattamento di affezioni del cavo orale
IT8722031A0 (it) Formulazioni farmaceutiche e forme di dosaggio per la somministrazione rettale di calcitonina.
IT9021021A0 (it) Composizioni farmaceutiche per la somministrazione orale di irudina
ITMI911445A1 (it) Impiego di derivati fosfolipidici per la preparazione di composizioni farmaceutiche aventi attivita' immunosoppressiva
ITMI913510A1 (it) Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita'
ITMI920214A0 (it) Composizioni farmaceutiche stabili per la somministrazione orale di calcitonina
IT1237197B (it) Formulazioni farmaceutiche anidre e forme di dosaggio per la somministrazione rettale di calcitonina.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19940203